| |
|
Form Serial Number: |
DA20210721E00424
|
| 1.
Date of relevant event: |
07/07/2021
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02219 |
| 4.
Name of listed corporation: |
朝聚眼科醫療控股有限公司 |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
687,500,000 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Zhang |
| (Other names) |
Wenwen |
|
|
|
| 10.
Name of director (Chinese): |
张文雯 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1701 | Miscellaneous
On listing of the corporation or a class of shares of the listed corporation |
|
|
| 2201 | Interest of corporation controlled by you |
|
36,465,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| | | |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 36,465,000 | 5.30 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 西藏隆博企業管理有限公司 | 西藏自治區拉薩市柳梧新區柳梧大廈307-C-1 | 張文雯 | 99.90 | N | |
| 北京惠譽達股權投資管理中心（有限合夥） | 北京市石景山區蘋果園南路23號1幢1層0113 | 西藏隆博企業管理有限公司 | 4.00 | N | |
| 陽光融匯資本投資管理有限公司 | 廈門市集美區杏林灣路492號2103單元A28 | 北京惠譽達股權投資管理中心（有限合夥） | 45.00 | N | |
| 北京陽光融匯醫療健康產業成長投資管理中心（有限合夥） | 北京市豐台區東管頭1號2號樓1-09室 | 陽光融匯資本投資管理有限公司 | 0.50 | Y | |
| 北京融匯陽光潤豐投資管理中心（有限合夥） | 北京市豐台區長辛店崔村二裡18號8幢1層126 | 陽光融匯資本投資管理有限公司 | 2.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
西藏隆博企業管理有限公司為北京惠譽達股權投資管理中心（有限合夥）的普通合夥人，因此西藏隆博企業管理有限公司被視為控制北京惠譽達股權投資管理中心（有限合夥）。陽光融匯資本投資管理有限公司分別為北京陽光融匯醫療健康產業成長投資管理中心（有限合夥）和北京融匯陽光潤豐投資管理中心（有限合夥）的普通合夥人，因此陽光融匯資本投資管理有限公被視為控制北京陽光融匯醫療健康產業成長投資管理中心（有限合夥）和北京融匯陽光潤豐投資管理中心（有限合夥）。
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
0
|
|
Date of filing this Form 3A: |
21/07/2021
(dd/mm/yyyy)
|
| |